image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - GB
$ 1.2249
1.63 %
$ 2.79 M
Market Cap
-0.4
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--
EBIT Estimate
--
Net Income Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Akanda Corp.
image
AKAN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart AKAN

image
AKAN has no estimates for Revenue Forecast.
$3.0m$3.0m$2.5m$2.5m$2.0m$2.0m$1.5m$1.5m$1.0m$1.0m$500.0k$500.0k$0.0$0.0201920192020202020212021202220222023202320242024
EBIT FORECAST

EBIT Forecast Chart AKAN

image
AKAN has no estimates for EBIT Forecast.
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)201920192020202020212021202220222023202320242024
NET INCOME FORECAST

Net Income Chart AKAN

image
AKAN has no estimates for Net Income.
$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)201920192020202020212021202220222023202320242024